Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 7, 2021; 27(41): 7125-7133
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7125
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7125
CT | MRI | |
Primary and metastatic GISTs | Small: Homogeneous mass; Large: Hypervascular, enhancing masses with heterogeneity due to hemorrhage, cystic degeneration, or necrosis | Depend on the amount of hemorrhage, necrosis and cystic degeneration; solid tumor components with low T1 signal, intermediate-to-high T2 signal, and enhancement; low mean ADC values may predict high malignancy potential |
Treatment response | Homogeneously hypoattenuating mass with decreased enhancing tumor nodules and intratumoral vessels | Increased T2 signal, increased cystic degeneration of solid tumoral components, increased ADC values |
Disease recurrence | Development of enhancing tumor nodules within the treated hypoattenuating tumor | New peripheral thickening and enhancement of cystic tumor |
- Citation: Wang MX, Devine C, Segaran N, Ganeshan D. Current update on molecular cytogenetics, diagnosis and management of gastrointestinal stromal tumors. World J Gastroenterol 2021; 27(41): 7125-7133
- URL: https://www.wjgnet.com/1007-9327/full/v27/i41/7125.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i41.7125